A novel antibody against human factor B that blocks formation of the C3bB proconvertase and inhibits complement activation in disease models.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Agustín Tortajada Oscar Llorca Bryan Paul Morgan Santiago Rodriguez de Córdoba |
| Publication date | October 29, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |